---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-154380"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:27:30.810689+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics draws $3.3M from Pershing facility to repay Oxford term loan in full

## Summary
- Drew $3.3M from Pershing margin loan facility at FOMC target (floor 5.5%) + 1.75% spread + 0.5% fees, max Prime+3%.
- On June 3, 2024, used the draw to repay and terminate the Oxford Finance term loan, totaling approx. $3.3M.
- Repayment eliminated Oxford's security interest in all of Plus Therapeutics' assets and related covenants.
- Pershing credit line is secured by collateralized marketable securities; can draw up to 91.5% of collateral value.
- Outstanding balance is due on demand; Pershing may require additional collateral or liquidate securities upon default.

## SEC filing metadata
- accession: 0001193125-24-154380
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312524154380/0001193125-24-154380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312524154380/d840235d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-154380
- JSON: https://secwatch.observer/filing/0001193125-24-154380.json
- Plain text: https://secwatch.observer/filing/0001193125-24-154380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.